USHY | XCCC | USHY / XCCC | |
Gain YTD | 5.076 | 3.993 | 127% |
Net Assets | 23.8B | 157M | 15,159% |
Total Expense Ratio | 0.08 | 0.40 | 20% |
Turnover | 21.00 | 49.00 | 43% |
Yield | 6.70 | 10.32 | 65% |
Fund Existence | 8 years | 3 years | - |
USHY | XCCC | |
---|---|---|
RSI ODDS (%) | 4 days ago51% | 4 days ago50% |
Stochastic ODDS (%) | 4 days ago52% | 4 days ago42% |
Momentum ODDS (%) | 7 days ago57% | 4 days ago78% |
MACD ODDS (%) | 4 days ago49% | 4 days ago85% |
TrendWeek ODDS (%) | 4 days ago59% | 4 days ago76% |
TrendMonth ODDS (%) | 4 days ago55% | 4 days ago75% |
Advances ODDS (%) | 4 days ago61% | 4 days ago77% |
Declines ODDS (%) | N/A | 24 days ago59% |
BollingerBands ODDS (%) | 4 days ago40% | 4 days ago60% |
Aroon ODDS (%) | 4 days ago54% | 4 days ago69% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QABA | 57.49 | 0.53 | +0.93% |
First Trust NASDAQ® ABA Community Bk ETF | |||
BBP | 59.73 | 0.31 | +0.51% |
Virtus LifeSci Biotech Products ETF | |||
IBMQ | 25.41 | 0.03 | +0.12% |
iShares iBonds Dec 2028 Term Muni Bd ETF | |||
BSCP | 20.70 | 0.01 | +0.05% |
Invesco BulletShares 2025 Corp Bd ETF | |||
HBMBF | 204.00 | N/A | N/A |
HBM Bioventures AG |
A.I.dvisor tells us that XCCC and BBGI have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XCCC and BBGI's prices will move in lockstep.
Ticker / NAME | Correlation To XCCC | 1D Price Change % | ||
---|---|---|---|---|
XCCC | 100% | +0.16% | ||
BBGI - XCCC | 6% Poorly correlated | -0.73% |